Testing troriluzole for methamphetamine use disorder
Treatments studied
Part of Mental health clinical trials.
This study tests whether a medication called troriluzole can help people who use methamphetamine. If you have methamphetamine use disorder and are not seeking treatment right now, this study may be an option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 55 years old
- You have used methamphetamine recently and have a diagnosis of methamphetamine use disorder
- You are not currently trying to quit or get treatment for drug use
- You are generally healthy (aside from methamphetamine use) and not taking daily prescription medicines for a chronic condition
- You do not have high blood pressure, a history of seizures, diabetes, asthma, or other serious medical or mental health conditions
- If you are a woman, you must use effective birth control and not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether people who use methamphetamine can reduce use even if they are not completely abstinent. It offers a 12-week program and checks how you're doing for another 12 weeks after.
This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.
This study tests whether a high dose of a stimulant medication (lisdexamfetamine, an ADHD medicine) taken over many weeks can help people who have already completed a methamphetamine treatment program to stay off meth, reduce use, or avoid relapse.
This study tests whether tirzepatide, a medication that may help reduce cravings and weight, can help people who use methamphetamine cut down or stop. It aims to find a new treatment option for methamphetamine use disorder.
This trial tests whether psilocybin, a psychedelic substance, can help people with moderate to severe methamphetamine use disorder reduce or stop their use. It may work by helping the brain reset, but it's not a standard treatment and involves careful monitoring.
This trial tests whether psilocybin (a psychedelic medicine) can help people quit methamphetamine. You'll receive counseling before, during, and after the drug session, and your progress will be followed for several months.
Hear when a new Methamphetamine Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.